• Je něco špatně v tomto záznamu ?

Expression of RAN, ZHX-2, and CHC1L genes in multiple myeloma patients and in myeloma cell lines treated with HDAC and Dnmts inhibitors

S. Legartova, A. Harnicarova-Horakova, E. Bartova, R. Hajek, L. Pour, S. Kozubek,

. 2010 ; 57 (5) : 482-7.

Jazyk angličtina Země Slovensko

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc12026318

Real time PCR is a powerful tool for studying the expression of genes involved in the pathophysiology of human diseases. Recent studies of the RAN (6p21), ZHX-2 (8q24.3), CHC1L (13q14.3) loci highlight the importance of these genes in multiple myeloma (MM) prognosis and therapeutic applications. Here, we described a detailed Real-Time PCR method for the detection of RAN, ZHX-2, and CHC1L expression, which could be applied in clinical situations. The expression profiles of these genes were studied in peripheral blood lymphocytes of healthy individuals, patients suffering from MM, and in the myeloma cell line, MOLP-8. Low expression levels of RAN, ZHX-2, and CHC1L were observed in myeloma patients, compared with peripheral blood lymphocytes and MOLP-8 cells. An inhibitor of histone deacetylases (TSA) had the ability to decrease expression of CHC1L and ZHX-2 in MOLP-8 cells, while expression of RAN was relatively stable in peripheral blood lymphocytes, control MOLP-8, and TSA- or 5-azacytidine treated MOLP-8 cells. In myeloma patients, we observed significant decreases in the expression of selected genes, but it was patient-specific. Our experiments illustrate new methodological approaches and troubleshooting for conducting gene expression studies in clinical laboratories.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc12026318
003      
CZ-PrNML
005      
20170621135609.0
007      
ta
008      
120817s2010 xo f 000 0#eng||
009      
AR
024    7_
$a 10.4149/neo_2010_05_482 $2 doi
035    __
$a (PubMed)20568903
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xo
100    1_
$a Legartova, S $u Institute of Biophysics, Academy of Sciences of the Czech Republic, Brno, Czech Republic.
245    10
$a Expression of RAN, ZHX-2, and CHC1L genes in multiple myeloma patients and in myeloma cell lines treated with HDAC and Dnmts inhibitors / $c S. Legartova, A. Harnicarova-Horakova, E. Bartova, R. Hajek, L. Pour, S. Kozubek,
520    9_
$a Real time PCR is a powerful tool for studying the expression of genes involved in the pathophysiology of human diseases. Recent studies of the RAN (6p21), ZHX-2 (8q24.3), CHC1L (13q14.3) loci highlight the importance of these genes in multiple myeloma (MM) prognosis and therapeutic applications. Here, we described a detailed Real-Time PCR method for the detection of RAN, ZHX-2, and CHC1L expression, which could be applied in clinical situations. The expression profiles of these genes were studied in peripheral blood lymphocytes of healthy individuals, patients suffering from MM, and in the myeloma cell line, MOLP-8. Low expression levels of RAN, ZHX-2, and CHC1L were observed in myeloma patients, compared with peripheral blood lymphocytes and MOLP-8 cells. An inhibitor of histone deacetylases (TSA) had the ability to decrease expression of CHC1L and ZHX-2 in MOLP-8 cells, while expression of RAN was relatively stable in peripheral blood lymphocytes, control MOLP-8, and TSA- or 5-azacytidine treated MOLP-8 cells. In myeloma patients, we observed significant decreases in the expression of selected genes, but it was patient-specific. Our experiments illustrate new methodological approaches and troubleshooting for conducting gene expression studies in clinical laboratories.
650    _2
$a azacytidin $x farmakologie $7 D001374
650    _2
$a nádorové buněčné linie $7 D045744
650    _2
$a inhibitory histondeacetylas $x farmakologie $7 D056572
650    _2
$a homeodoménové proteiny $x genetika $7 D018398
650    _2
$a lidé $7 D006801
650    _2
$a kyseliny hydroxamové $x farmakologie $7 D006877
650    _2
$a mnohočetný myelom $x farmakoterapie $x genetika $7 D009101
650    _2
$a nádorové proteiny $x genetika $7 D009363
650    _2
$a transkripční faktory $x genetika $7 D014157
650    _2
$a ran protein vázající GTP $x genetika $7 D020931
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Harnicarova-Horakova, A
700    1_
$a Bartova, E
700    1_
$a Hajek, R
700    1_
$a Pour, Luděk $7 xx0102556
700    1_
$a Kozubek, S
773    0_
$w MED00003470 $t Neoplasma $x 0028-2685 $g Roč. 57, č. 5 (2010), s. 482-7
856    41
$u https://pubmed.ncbi.nlm.nih.gov/20568903 $y Pubmed
910    __
$a ABA008 $b A 1194 $c 659 $y m $z 0
990    __
$a 20120817 $b ABA008
991    __
$a 20170621140028 $b ABA008
999    __
$a ok $b bmc $g 948360 $s 783664
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2010 $b 57 $c 5 $d 482-7 $i 0028-2685 $m Neoplasma $n Neoplasma $x MED00003470
LZP    __
$a Pubmed-20120817/10/04

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace